Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression.
Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression.
复制标题
HLA-B*81:01- 和 HLA-B*39:10 介导的 HIV-1 p24 序列进化与疾病进展的时间关联。
DOI:
10.1128/jvi.00539-12
复制
发表时间:
2012
影响因子:
5.4
通讯作者:
CAPRISA002StudyTeam
中科院分区:
文献类型:
--
作者:
Ntale,RS;Chopera,DR;Ngandu,NK;AssisdeRosa,D;Zembe,L;Gamieldien,H;Mlotshwa,M;Werner,L;Woodman,Z;Mlisana,K;AbdoolKarim,S;Gray,CM;Williamson,C;CAPRISA002StudyTeam
HLA-B*81:01 and HLA-B*39:10 alleles have been associated with viremic control in HIV-1 subtype C infection. Both alleles restrict the TL9 epitope in p24 Gag, and cytotoxic-T-lymphocyte (CTL)-mediated escape mutations in this epitope have been associated with anin vitrofitness cost to the virus. We investigated the timing and impact of mutations in the TL9 epitope on disease progression in five B*81:01- and two B*39:10-positive subtype C-infected individuals. Whereas both B*39:10 participants sampled at 2 months postinfection had viruses with mutations in the TL9 epitope, in three of the five (3/5) B*81:01 participants, TL9 escape mutations were only detected 10 months after infection, taking an additional 10 to 15 months to reach fixation. In the two remaining B*81:01 individuals, one carried a TL9 escape variant at 2 weeks postinfection, whereas no escape mutations were detected in the virus from the other participant for up to 33 months postinfection, despite CTL targeting of the epitope. In all participants, escape mutations in TL9 were linked to coevolving residues in the region of Gag known to be associated with host tropism. Late escape in TL9, together with coevolution of putative compensatory mutations, coincided with a spontaneous increase in viral loads in two individuals who were otherwise controlling the infection. These results providein vivoevidence of the detrimental impact of B*81:01-mediated viral evolution, in a single Gag p24 epitope, on the control of viremia.